Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10022813HBVENSG00000197081.16protein_codingIGF2RNoNo3482P11717
TVIS10030717HBVENSG00000197081.16protein_codingIGF2RNoNo3482P11717
TVIS10023433HBVENSG00000197081.16protein_codingIGF2RNoNo3482P11717
TVIS10030718HBVENSG00000197081.16protein_codingIGF2RNoNo3482P11717
TVIS10018974HBVENSG00000197081.16protein_codingIGF2RNoNo3482P11717
TVIS10019408HBVENSG00000197081.16protein_codingIGF2RNoNo3482P11717
TVIS30077151HIVENSG00000197081.16protein_codingIGF2RNoNo3482P11717
TVIS30081701HIVENSG00000197081.16protein_codingIGF2RNoNo3482P11717
TVIS30078423HIVENSG00000197081.16protein_codingIGF2RNoNo3482P11717
TVIS30066178HIVENSG00000197081.16protein_codingIGF2RNoNo3482P11717
TCGA Plot Options
Drug Information
GeneIGF2R
DrugBank IDDB13173
Drug NameCerliponase alfa
Target IDBE0003623
UniProt IDP11717
Regulation Typeligand
PubMed IDs22792360
CitationsMeng Y, Sohar I, Wang L, Sleat DE, Lobel P: Systemic administration of tripeptidyl peptidase I in a mouse model of late infantile neuronal ceroid lipofuscinosis: effect of glycan modification. PLoS One. 2012;7(7):e40509. doi: 10.1371/journal.pone.0040509. Epub 2012 Jul 6.
GroupsApproved; Investigational
Direct ClassificationPeptides
SMILES
Pathways
PharmGKB
ChEMBLCHEMBL3544921